Clinical Trial

Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

Study acronym: ISAR-DESIRE5
Recruiting
View on ClinicalTrials.gov →
Summary
The hypothesis of the study is, that there is a significant interaction in treatment effect between the OCT pattern of neointima (heterogeneous or homogeneous) and the type of percutaneous coronary intervention (drug-eluting stent or drug-coated balloon) in patients with in-stent restenosis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-09-15; most recent amendment 2025-01-03.
Status change: Not Yet Recruiting → Recruiting 2022-10-12
Trial Details
NCT Number NCT05544864
Lead Sponsor Deutsches Herzzentrum Muenchen
Collaborators: EvidentIQ Germany GmbH, Abbott, Technical University of Munich
Conditions Coronary Artery Disease, Restenoses, Coronary
Enrollment 376 participants
Start Date 2022-09-28
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-01-06